The new “Distraction in Action” application developed at the University of Iowa helps children remain preoccupied while receiving a shot.
News
Research on a new drug to treat a rare form of muscular dystrophy was in-part conducted at the University of Iowa. The drug was recently approved by the Food and Drug Administration (FDA).
Patient Engagement: A New Frontier in Clinical Research
Congratulations to University of Iowa College of Education Assistant Professor Armeda Wojciak, PhD, LMFT and Clinical Associate Professor Carol Smith, PhD, LPC, NCC for receiving an external implementation grant ($87,718) from the Center for Educational Transformation from the University of Northern Iowa.
Brooke Finney and Brooklyn Pardall, freshmen from Central Lee High School in Donnellson, IA, recently visited the Institute for Clinical and Translational Science (ICTS) at the University of Iowa to meet with UI pulmonary researchers and visit some of our facilities.
Congrats to the winners in the ICTS poster competitions that took place during the 2016 Health Sciences Research Week. Each winner received $350.
Congrats to 2016 Goldwater Scholar Nicolas McCarty, a third-year biochemistry student working in Dale Abel's lab. Niko primarily studies the role of insulin signaling in regulating the cardiovascular system. He's currently pursing an ICTS Certificate in Clinical and Translational Studies, a program designed for undergraduates who are interested in connecting their research to the translational spectrum
Ann Rhomberg, RN/MSN, is a Clinical/Health Care Research Associate who has worked at University of Iowa Hospitals and Clinics for three years. Ann, a valued member of the ICTS Research Coordinator Core, was recently recognized as one of the top recruiters in the world for the North American arm of the Study Of Diabetic Nephropathy With Atrasentan (SONAR study).
A University of Iowa-led study in mice shows that a hormone produced by the liver, fibroblast growth factor 21 (FGF21), suppresses the consumption of simple sugars. The researchers report that FGF21 is produced in the liver in response to high carbohydrate levels. FGF21 then enters the bloodstream, where it sends a signal to the brain to suppress the preference for sweets.
Dr. Eric Dyken of the UI Sleep Disorders Center fields questions about the benefits and drawbacks of sharing a room with a sleeping partner. He also discusses how gene changes in an aging brain affect circadian rhythm, and new research on the dangers of giving melatonin to young children.